These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17938209)

  • 21. Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation.
    Meng G; Zhao Y; Nag A; Zeng M; Dimri G; Gao Q; Wazer DE; Kumar R; Band H; Band V
    J Biol Chem; 2004 Dec; 279(52):54230-40. PubMed ID: 15496419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
    Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
    Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator.
    Talukder AH; Gururaj A; Mishra SK; Vadlamudi RK; Kumar R
    Mol Cell Biol; 2004 Aug; 24(15):6581-91. PubMed ID: 15254226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menin links estrogen receptor activation to histone H3K4 trimethylation.
    Dreijerink KM; Mulder KW; Winkler GS; Höppener JW; Lips CJ; Timmers HT
    Cancer Res; 2006 May; 66(9):4929-35. PubMed ID: 16651450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression.
    Klinge CM; Silver BF; Driscoll MD; Sathya G; Bambara RA; Hilf R
    J Biol Chem; 1997 Dec; 272(50):31465-74. PubMed ID: 9395481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression.
    Mowery CT; Reyes JM; Cabal-Hierro L; Higby KJ; Karlin KL; Wang JH; Kimmerling RJ; Cejas P; Lim K; Li H; Furusawa T; Long HW; Pellman D; Chapuy B; Bustin M; Manalis SR; Westbrook TF; Lin CY; Lane AA
    Cell Rep; 2018 Nov; 25(7):1898-1911.e5. PubMed ID: 30428356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression.
    Xu X; Murdoch FE; Curran EM; Welshons WV; Fritsch MK
    Gene; 2004 Mar; 328():143-51. PubMed ID: 15019994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Sp3 and estrogen receptor alpha with the transcriptionally active trefoil factor 1 promoter in MCF-7 breast cancer cells.
    Li L; Davie JR
    J Cell Biochem; 2008 Oct; 105(2):365-9. PubMed ID: 18543253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitogen- and stress-activated protein kinases 1 and 2 are required for maximal trefoil factor 1 induction.
    Khan P; Drobic B; Pérez-Cadahía B; Healy S; He S; Davie JR
    PLoS One; 2013; 8(5):e63189. PubMed ID: 23675462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains.
    Choi YB; Ko JK; Shin J
    J Biol Chem; 2004 Dec; 279(49):50930-41. PubMed ID: 15456770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
    Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
    Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene.
    Chatagnon A; Ballestar E; Esteller M; Dante R
    PLoS One; 2010 Mar; 5(3):e9665. PubMed ID: 20300195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes.
    Furusawa T; Lim JH; Catez F; Birger Y; Mackem S; Bustin M
    Mol Cell Biol; 2006 Jan; 26(2):592-604. PubMed ID: 16382150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.
    Abuhatzira L; Shamir A; Schones DE; Schäffer AA; Bustin M
    J Biol Chem; 2011 Dec; 286(49):42051-42062. PubMed ID: 22009741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
    Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.
    Jeffy BD; Hockings JK; Kemp MQ; Morgan SS; Hager JA; Beliakoff J; Whitesell LJ; Bowden GT; Romagnolo DF
    Neoplasia; 2005 Sep; 7(9):873-82. PubMed ID: 16229810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone H3R17me2a mark recruits human RNA polymerase-associated factor 1 complex to activate transcription.
    Wu J; Xu W
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5675-80. PubMed ID: 22451921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation.
    Loven MA; Muster N; Yates JR; Nardulli AM
    Mol Endocrinol; 2003 Jan; 17(1):67-78. PubMed ID: 12511607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
    J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.